Buradasınız

Sekiz yaşındaki bir kız çocuğunda psödoefedrin kullanımına bağlı gelişen ventriküler aritmi

Ventricular arrythmia due to pseudoephedrine usage at a eight years old girl

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Common cold is one of the most frequently observed infections in childhood. Pseudoephedrine hydrochloride (PEH) is a sympathomimetic drug which is widely used for treatment of colds in children. This case report is trying to get attention to potentional side effects of PEH as ventricular arrythmia in the treatment of colds.
Abstract (Original Language): 
Soğuk algınlığı, çocukluk çağının sık görülen hastalıklarından biridir. Psödoefedrin hidroklorür (PEH) yaygın olarak çocuklarda soğuk algınlığının tedavisinde kullanılan sempatomimetik bir ilaçtır. Bu olgu sunumunda, PEH kullanan bir çocuk hastada gelişen ventriküler aritmi tanımlanmış olup, PEH tedavisinin olası yan etkilerine dikkat çekmek amaçlanmıştır.
36-38

REFERENCES

References: 

1. Pappas DE, Hayden GF, Hendley JO. Treating colds:
keep it simple. Contemp Pediatr 1999; 16:109-119.
2. Nash DR, Harman J, Wald ER, Kelleher KJ.
Antibiotic prescribing by primary care physicians for
children with upper respiratory tract infections. Arch
Pediatr Adolesc Med 2002; 156:1114-1119.
3. Vernacchio L, Kelly JP, Kaufman DW, Mitchell AA.
Pseudoephedrine use among us children, 1996-2006:
result from the slone survey. Pediatrics 2008;
122:1299-1304.
4. Aljazaf K, Hale TW, Ilett KF, Hartmann PE, Mitoulas
LR, Kristensen JH, et al. Pseudoephedrine: effects on
milk production in women and estimation of infant
exposure via breastmilk. Br J Clin Pharmacol 2003;
56:18-24.
5. Gill ND, Shield A, Blazevic AJ, Zhou Z, Weatherby
RP. Muscular and cardioespiratory effect of
pseudoephedrine in human athletes. Br J Clin
Pharmacol 2000; 50:205-213.
6. US Food and Drug Administration. Sales of
Supplements Containing Ephedrine Alkaloids
(Ephedra) Prohibited.
http://www.fda.gov/oc/initiatives/ephedra/february200
4. (10 Ekim 2008’de erişilmiştir).
7. Kasper DL. Harrison’s manual of medicine. Blacklick,
OH. McGraw-Hill Companies; 2005.
8. Empey DW, Young GA, Letley E, John GC, Smith P,
McDonnell KA, Bagg LR, Hughes DT. Dose-response
study of the nasal decongestant and cardiovascular
effects of pseudoephedrine. Br J Clin Pharmacol 1980;
9:351-358.
9. Celik A. ST elevation myocardial ınfarction presenting
after use of pseudoephedrine. Cardiovasc Toxicol
2009; 9:103–104.
10. Akay S, Ozdemir M. Acute coronary syndrome
presenting after pseudoephedrine use and regression
with beta-blocker therapy. Can J Cardiol 2008; 24:86-
88.
11. Manini FA, Kabrhel C, Thomsen TW. Acute
myocardial infarction after over-the-counter use of
pseudoephedrine. Ann Emerg Med 2005; 45:217–218.
12. Hutton N, Wilson MH, Mellits ED, Baumgardner R,
Wissow LS, Bonuccelli C, et al. Effectiveness of an
antihistamine-decongestant combination for young
children with the common cold: a randomized,
controlled clinical trial. J Pediatr 1991; 118:125-130.
İletişim:
Dr. Cenk Aypak
Dışkapı Yıldırım Beyazıt Eğitim Araştırma Hastanesi,
Aile Hekimliği Kliniği, Ankara, Türkiye.
Tel: +90.312.3186981-514.
e-mail: cenkaypak@yahoo.com

Thank you for copying data from http://www.arastirmax.com